Prioritization of Biomarker Targets in Human Umbilical Cord Blood: Identification of Proteins in Infant Blood Serving as Validated Biomarkers in Adults.

Background: Early diagnosis represents one of the best lines of defense in the fight against a wide array of human diseases. Umbilical cord blood (UCB) is one of the first easily available diagnostic biofluids and can inform about the health status of newborns. However, compared with adult blood, it...

Descripción completa

Detalles Bibliográficos
Publicado en:Environmental Health Perspectives Vol. 120; no. 5; pp. 764 - 770
Autores principales: Hansmeier, Nicole, Chao, Tzu-Chiao, Goldman, Lynn R., Witter, Frank R., Halden, Rolf U.
Formato: research tables/charts Journal Article
Publicado: National Institute of Environmental Health Sciences May2012
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104445875&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104445875
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00916765
        3B5
      jtl: Environmental Health Perspectives
      issn: 00916765
      maglogo: N
    pubinfo:
      dt: May2012
      vid: 120
      iid: 5
      pid: 56539
      pub: National Institute of Environmental Health Sciences
      place: Research Triangle Park, North Carolina
    artinfo:
      ui:
        104445875
        75164993
        10.1289/ehp.1104190
        NLM22538116
        104445875
      ppf: 764
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Prioritization of Biomarker Targets in Human Umbilical Cord Blood: Identification of Proteins in Infant Blood Serving as Validated Biomarkers in Adults.
      aug:
        au:
          Hansmeier, Nicole
          Chao, Tzu-Chiao
          Goldman, Lynn R.
          Witter, Frank R.
          Halden, Rolf U.
        affil: Swette Center for Environmental Biotechnology, Biodesign Institute, Arizona State University, Tempe, Arizona, USA
      sug:
        subj:
          Biological Markers Blood
          Fetal Blood Analysis
          Proteins Blood
          Human
          Infant, Newborn
          Chromatography, Liquid
          Mass Spectrometry
          Proteomics
          United States
          Funding Source
          Infant, Newborn: birth-1 month
      ab: Background: Early diagnosis represents one of the best lines of defense in the fight against a wide array of human diseases. Umbilical cord blood (UCB) is one of the first easily available diagnostic biofluids and can inform about the health status of newborns. However, compared with adult blood, its diagnostic potential remains largely untapped. Objectives: Our goal was to accelerate biomarker research on UCB by exploring its detectable protein content and providing a priority list of potential biomarkers based on known proteins involved in disease pathways. Methods: We explored cord blood serum proteins by profiling a UCB pool of 12 neonates with different backgrounds using a combination of isoelectric focusing and liquid chromatography coupled with matrix-assisted laser desorption/ionization tandem mass spectrometry (MALDI-MS/MS) and by comparing results with information contained in metabolic and disease databases available for adult blood. Results: A total of 1,210 UCB proteins were identified with a protein-level false discovery rate of ~ 5% as estimated by naïve target-decoy and MAYU approaches, signifying a 6-fold increase in the number of UCB proteins described to date. Identified proteins correspond to 138 different metabolic and disease pathways and provide a platform of mechanistically linked biomarker candidates for tracking disruptions in cellular processes. Moreover, among the identified proteins, 38 were found to be approved biomarkers for adult blood. Conclusions: The results of this study advance current knowledge of the human cord blood serum proteome. They showcase the potential of UCB as a diagnostic medium for assessing infant health by detection and identification of candidate biomarkers for known disease pathways using a global, nontargeted approach. These biomarkers may inform about mechanisms of exposure-disease relationships. Furthermore, biomarkers approved by the U.S. Food and Drug Administration for screening in adult blood were detected in UCB and represent high-priority targets for immediate validation.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N